| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.2M | -9.5% |
| Cost of Revenue | $4.7M | -25.1% |
| Gross Profit | $2.5M | +50.5% |
| R&D Expense | $68K | -88.4% |
| SG&A Expense | $1.1M | -26.3% |
| Operating Income | -$904K | +76.0% |
| Income Tax | $0 | — |
| Net Income | -$896K | +76.2% |
| EPS (Basic) | -$0.08 | +84.0% |
| EPS (Diluted) | -$0.08 | +84.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -32.6% |
| Accounts Receivable | $918K | +34.9% |
| Current Assets | $2.7M | -18.3% |
| Total Assets | $2.8M | -24.6% |
| Current Liabilities | $675K | +10.0% |
| Total Liabilities | $675K | -15.7% |
| Stockholders' Equity | $2.1M | -27.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$448K | +84.7% |
| Capital Expenditures | $107 | -99.0% |
| Investing Cash Flow | -$107 | +99.0% |
| Financing Cash Flow | -$333K | -116.2% |
| Free Cash Flow | -$448K | +84.8% |